These results show promise for the therapeutic use of IN insulin as a weight management option for women with obesity, particularly those with co-morbid mood disorders and further investigation of the longer-term effects of the hormone on weight in women with obesity is warranted. The gene discussed is INS; the disease is obesity due to melanocortin 4 receptor deficiency.